Tuesday, 6 December, 2022
09:00 - 12:00
Harnessing the Power of Dosimetry for Improved Outcomes
The role of this practice is one of the most controversial topics in radiopharmaceuticals; however, a new wave of medical physicists is bringing a fresh perspective to this area. One consistent idea is that no dosimetry protocol is perfect.
Attend this workshop to understand:
• How do you determine your precise goal when implementing dosimetry into your study?
• What should the key parameters of your study be?
• A comparison of several well-known and lesser-known protocols, including the 3+3 Dosimetry dose escalation, computational methods and more
• Best practice when analysing the results of a dosimetry study
Director of the Radiation Research Unit
Istituto Europeo di Oncologia
Department of Radiation Physics
13:00 - 16:00
Discovery Tools for the Next Generation of Radiopharmaceuticals
Discovery – High throughput chromatography, combined with
new technologies including AI/ML, in silico protein modelling and advanced protein engineering tools are how we will get
the best, cleanest targets.
Join this workshop to explore the capabilities of these tools and find out how these could be integrated seamlessly into your drug development process.
Discuss how best you can interpret the results and make the best decisions when selecting your primary candidates.
Finally, as a group we will discuss the strategies that the field could use to start exploring opportunities outside of PSMA.
Including what can be learnt from other successful fields that implement antibody-based targeting systems, such as ADC.
Chief Executive Officer